Gene editing
Overview
Gene editing is a topic in the health domain with significant developments in policy, regulation, and public health impact.
Key developments include arpa-h launches $160 million gene editing drug development program, broad institute, boston children's hospital, and jackson laboratory launch $160 million center for rare disease gene therapies, breakthrough prize awards $3 million to researchers behind first sickle cell crispr therapy, among other significant events and policy changes.